GC Biopharma's licensed flu vaccine gets approval in Taiwan

Taiwan's Medigen plans to establish a local production system using vaccine manufacturing technology transferred from GC

GC Biopharma's licensed flu vaccine gets approval in Taiwan
Jeong Min Nam 1
2023-03-13 14:11:36 peux@hankyung.com
Bio & Pharma

South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the Taiwanese Food and Drug Administration within the Ministry of Health and Welfare.

The company licensed the vaccine to Medigen Vaccine Biologics Corporation, a pharmaceutical company based in Taiwan, as part of their technology transfer partnership signed in 2018.

As per the licensing agreement, GC Biopharma will supply Medigen with the flu vaccine stock solution, while Medigen will use the transferred vaccine manufacturing technology to establish a local production system.

GC Biopharma aims to use the Taiwanese market as a stepping stone to accelerate the localization of vaccine production and build a global vaccine infrastructure based on their strong vaccine technology accumulated over half a century, according to Huh Eun-chul, CEO of GC Biopharma.

Write to Jeong Min Nam at peux@hankyung.com
#GC Biopharma #Medigen Vaccine Biologics #Taiwanese Food and Drug Administration #quadrivalent flu vaccine #korea gc taiwan #korea gc biopharma taiwan

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The drug maker said it has exercised an option contract with Acuitas Therapeutics, a Canadian pharma that specializes in lipid nano particle (LNP) deliv

GC Biopharma introduces candidates for treating blood coagulation disease

GC Biopharma introduces candidates for treating blood coagulation disease

Nassim Usman, CEO of Catalyst Biosciences(left) and Huh Eun-chul, CEO of GC Biopharma South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based drug development firm, in order to introduce drug candidates

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter the World Health Organization (WHO) procurement market with Barycela following its export hit Suduvax. This breakthrough is expected to heat up glob

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma, Sanofi to jointly market Plavix

Plavix GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Korean subsidiary of multinational pharmaceuticals company Sanofi, for Plavix 75 mg, an antiplatelet medication.The agreement calls for GC Bioph
(* comment hide *}